CytomX Therapeutics Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Analysis

CytomX Therapeutics, Inc. (CTMX)

4.41 -0.11 (-2.43%) USD | NASDAQ | Mar 30, 16:00

4.34 -0.07 (-1.59%) After-Hours: 20:00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for CTMX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Catalyst Pharmaceuticals, Inc.	Upgrade
Rigel Pharmaceuticals, Inc.	Upgrade
REGENXBIO, Inc.	Upgrade
Ovid Therapeutics, Inc.	Upgrade
Olema Pharmaceuticals, Inc.	Upgrade